Studies suggest that targeting both GLP-1 and GIP receptors together enhances insulin sensitivity, reduces fat accumulation, and may improve metabolic flexibilityall of which could contribute to greater weight loss compared to GLP-1 activation alone
Poletti S, Mazza MG, Benedetti F
These are practical barriers, but they are also adherence barriers
An answer from the agency is expected in 2024.
The goal of any modern weight loss journey is to create a lifestyle that is both healthy and enjoyable
In the general population prescribed GLP-1s, stopping the medications comes with a rebound in weight gain and related metrics, such as blood pressure, cholesterol and blood sugar